Shannon Connelly

Expert Discusses Biomarker Development in Prostate Cancer

April 28, 2017

Leonard Gomella, M.D., recommends that healthcare providers familiarize themselves with how each novel biomarker should be used and then decide which one to use for a more individualized approach in clinical practice.

The Future of Immunotherapy for Urothelial Carcinoma Treatment

April 07, 2017

In an interview with CURE, Evan Y. Yu, M.D., discusses the current treatment options for metastatic urothelial carcinoma, the unmet needs that still exist in this space and the possibilities for the future treatment landscape.